0 NYSE Companies - February 13, 2020NYSE American Approves Lilis’ Plan to Regain ComplianceFORT WORTH, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) — Lilis Energy, Inc. (NYSE American: LLEX) (the “Company”), an exploration and […]Read More
0 NYSE Companies - February 13, 2020Espey Mfg. & Electronics Corp. reports record backlog and second quarter resultsSARATOGA SPRINGS, N.Y., Feb. 13, 2020 (GLOBE NEWSWIRE) — Espey Mfg. & Electronics Corp. (NYSE American: ESP) announces results for the […]Read More
0 NYSE Companies - February 13, 2020Spirit Airlines Announces New $11 Million Operational Control Center in Greater Nashville AreaMIRAMAR, Fla., Feb. 13, 2020 (GLOBE NEWSWIRE) — America’s fastest-growing airline is expanding behind the scenes to support its growing […]Read More
0 NYSE Companies - February 13, 2020Occidental Announces DividendHOUSTON, Feb. 13, 2020 (GLOBE NEWSWIRE) — Occidental Petroleum Corporation (NYSE:OXY) said today that its Board of Directors has declared […]Read More
0 NYSE Companies - February 13, 2020Meritage Homes Introduces New Tree-Lined Community in Top-Rated Melissa School DistrictMELISSA, Texas, Feb. 13, 2020 (GLOBE NEWSWIRE) — Meritage Homes, the seventh-largest public homebuilder in the U.S., today announced the […]Read More
0 NYSE Companies - February 13, 2020FutureFuel to Release Year-End 2019 Financial Results on March 13, 2020CLAYTON, MO. , Feb. 13, 2020 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance […]Read More
0 NYSE Companies - February 13, 2020TC Energy files 2019 annual disclosure documentsCALGARY, Alberta, Feb. 13, 2020 (GLOBE NEWSWIRE) — TC Energy Corporation (TSX, NYSE: TRP) (TC Energy or the Company) has […]Read More
0 NYSE Companies - February 13, 2020Annovis Bio Announces Update on Phase II Clinical Trial for Alzheimer’s DiseaseBERWYN, Pa., Feb. 13, 2020 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing […]Read More
0 NYSE Companies - February 13, 2020AIM ImmunoTech подает три предварительные заявки на патент использования Ampligen® против схожего с вирусом SARS нового коронавируса Ухань 2019 годаAmpligen® достиг 100% выживаемости при клинически достижимых уровнях дозировки для человека при вирусе SARS в экспериментах на животныхAmpligen – ключ […]Read More
0 NYSE Companies - February 13, 2020DAT: January brought dramatic highs and lows to truckload freightPORTLAND, Ore., Feb. 13, 2020 (GLOBE NEWSWIRE) — Spot market truckload rates got a hot start in January, but quickly […]Read More